Vikas Chonira

Vikas Chonira has worked at Marengo Therapeutics since 2022 as a Scientist I. Prior to that, they were a Postdoctoral Research Associate at Texas A&M University from 2019 to 2022. Vikas'sresearch focus was engineering of DARPin based binding proteins to block key proteins involved in infectious and inflammatory diseases using phage display and rational design. Vikas engineered SARS2 neutralizing proteins (DARPins) using phage display, rationally designed protease resistant DARPins against Clostridium Difficile infection, characterized engineered proteins with Bio-layer interferometry (BLI), ELISA and mammalian cell culture with the goal of drug development, explored invitro cell free protein synthesis and display techniques, supervised graduate students with molecular cloning and protein purification, and engineered checkpoint inhibitors for cancer therapy.

Vikas Chonira obtained a Doctor of Philosophy - PhD in Protein Biochemistry from The University of Waikato between 2013 and 2018. Vikas also obtained certification from the Educational Commission for Foreign Medical Graduates, USA (ECFMG) in September 2009 and Board Certified Medical Affairs Specialist from the Accreditation Council for Medical Affairs (ACMA) in December 2021.